Searchable abstracts of presentations at key conferences in endocrinology

ea0035p211 | Clinical case reports Pituitary/Adrenal | ECE2014

Can bexarotene be a candidate drug for the medical therapy of Cushing's syndrome?

Atmaca Hulusi , Isikli Gulsen , Senturk Nilgun , Buyukkaya Piltan

We report a patient with mycosis fungoides treated with bexarotene (Targretin), a synthetic retinoid analog with specific affinity for retinoid X receptor. This patient developed hypopituitarism characterized by hypogonadism, hypothyroidism, and hypoadrenalism. Although central hypothyroidism is a common side effect of bexarotene, central hypogonadism, and hypoadrenalism has been reported in one case. Clinicians should have high index of suspicion for hypopituitarism in patien...